Y.Dana Presentation Cognitive Disorders
Y.Dana Presentation Cognitive Disorders
Y.Dana Presentation Cognitive Disorders
Cognitive Disorders
● Involve “assaults” on the human brain
● Cognition is associated with memory
and learning.
● The loss of memory and learning is
the common thread in all cognitive
disorders
● Some cognitive disorders are
temporary or “reversible” and some
are permanent or “irreversible”.
Classification
2. Dementia
◦ Subtle onset
◦ NOT the result of normal aging
◦ Sometimes referred to as the zone between
normal aging and Alzheimer's Disease.
◦ Forgetfulness is the hallmark symptom!
◦ It is not a DSM-IV-TR diagnosis
Delirium
• Reduced clarity of awareness with inability to focus, maintain or shift
attention
• Often accompanied by other cognitive deficits
• Disorientation to place, time, and situation
• Memory: Perseverating, short-term memory loss
• Language: dysarthria, word-finding, aphasia
• Perception: Misinterpretations, illusions, hallucinations
• Sleep: insomnia, circadian rhythm changes
• Emotion: heighten state, fear/anxiety, paranoia, restless, irritable
• Acute and definite shift from baseline
• Over half of patients return to pre-delirium status
• Often precedes worsening of condition in elderly and
chronically ill
Causes of Delirium
• Most cases of delirium are secondary to
another disease process
• Decompensated dementia
• Medication, anesthesia, chemical use/withdrawal
• Infection (sepsis, influenza, UTI)
• Electrolyte imbalances (Na+, glucose)
• Sleep deprivation
• Physiological stress
• Hypothermia, ICU patients
Dementia
• The occasional ‘senior moment’ is normal, further impairment
represents a pathology
Prevention
• Nutrition:
• Vitamin B deficiency
• Bouts of hypoglycemia
• Mental Activity
• Provide mental stimuli with learning language, music,
mental puzzles
• Physical Activity
• Daily exercise and hobbies
• Social Activity
• Family and friend interactions
• Pharmacological
Pharmacological Interventions
• Medications can prevent deterioration, but
cannot return lost abilities
• Cautious dosing
• Prevent breakdown of acetylcholine
• Early stages, GI and hepatic side effects, limit NSAID use
• Donezepil (aricept), rivastigmine (exelon), and
galantamine (razadyne)
• N-Methyl-D-Aspartate antagonist, limit
glutamate release to prevent neuro-corrosion
from calcium ions
• Moderate to severe stages, limit if renal impairment
• Mematine (Namenda)
Interventions
• Think fundamental and instinctual
• Creature comforts
• Natural bodily rhythms
• Safety precautions
• falls, pulling medical devices, wandering/elopement
• Frequently mention time, place, person etc.
• Maintain consistent routine
• Remove obnoxious stimuli
• Foley, noise from hall
• Communication: literal word choices
• one-step directions, 2 item choices, picture boards
References
◻ American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 1st edn
(American Psychiatric Association, 1952).
◻ Ganguli, M. et al. Classification of neurocognitive disorders in DSM‐5: a work in progress. Am. J.
Geriatr. Psychiatry 19, 205–210 (2011).
◻ 6. Sachdev, P. S. Is DSM‐5 defensible? Aust. N. Z. J. Psychiatry 47, 10–11 (2013).
◻ 7. Sternberg, R. J. & Sternberg, K. Cognitive Psychology 6th edn (Cengage Learning, 2009).
◻ 8. Sachdev, P., Andrews, G., Hobbs, M. J., Sunderland,M.&Anderson,T.M.Neurocognitive disorders:
cluster 1 of the proposed meta‐ structure for DSM‐V and ICD‐11. Psychol. Med. 39, 2001–2012
(2009).
◻ 9. Mesulam, M.‐M. (Ed.). Principles of Behavioral and Cognitive Neurology 2nd edn (Oxford
University Press, 2000).
◻ 10. Lezak, M. D., Howieson, D. B. & Loring, D. W. Neuropsychological Assessment 4th edn (Oxford
University Press, 2004).